United Capital Financial Advisers, LLC Dexcom Inc Transaction History

United Capital Financial Advisers, LLC

$19.9 Billion
Q3 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Dexcom Inc stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 11,248 shares of DXCM stock, worth $900,289. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,248

Previous 7,884 42.67%

Holding current value

$900,289

Previous $893,000 15.68%

% of portfolio

0.0%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $215,296 - $390,425	3,364 Added 42.67%	11,248 $753,000
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $242,020 - $308,147	-2,194 Reduced 21.77%	7,884 $893,000
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $62,249 - $76,354	-545 Reduced 5.13%	10,078 $1.4 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $385,149 - $633,464	-5,102 Reduced 32.45%	10,623 $1.32 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $519,286 - $832,269	-6,034 Reduced 27.73%	15,725 $1.47 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $61,071 - $71,122	543 Added 2.56%	21,759 $2.8 Million
Q1 2023 Aug 14, 2023	SELL	$104.0 - $122.92 $56,472 - $66,745	-543 Reduced 2.5%	21,216 $2.46 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $867,984 - $1.03 Million	-8,346 Reduced 28.23%	21,216 $2.46 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $34,586 - $49,926	-407 Reduced 1.36%	29,562 $3.35 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $147,813 - $182,332	-1,936 Reduced 6.07%	29,969 $2.41 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $1.64 Million - $3.2 Million	24,078 Added 307.63%	31,905 $2.38 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $68,584 - $94,915	729 Added 10.27%	7,827 $4 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $13,766 - $17,258	106 Added 1.52%	7,098 $3.81 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $6,082 - $8,161	-57 Reduced 0.81%	6,992 $3.82 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $32,800 - $43,711	405 Added 6.1%	7,049 $3.01 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $60,116 - $74,260	-709 Reduced 9.64%	6,644 $2.39 Million
Q4 2020 Feb 17, 2021	BUY	$78.0 - $104.5 $401,076 - $537,339	5,142 Added 232.56%	7,353 $2.72 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $8,786 - $10,391	-92 Reduced 3.99%	2,211 $911,000
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $9,840 - $16,538	-157 Reduced 6.38%	2,303 $934,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $7,885 - $12,478	165 Added 7.19%	2,460 $662,000
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $7,800 - $12,202	-213 Reduced 8.49%	2,295 $502,000
Q3 2019 Feb 14, 2020	BUY	$35.53 - $43.8 $89,109 - $109,850	2,508 New	2,508 $374,000
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $112,310 - $138,451	-3,161 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $15,005 - $20,977	539 Added 20.56%	3,161 $474,000
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $36,659 - $49,863	-1,306 Reduced 33.25%	2,622 $312,000
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $1,160 - $1,606	43 Added 1.11%	3,928 $471,000
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $725,904 - $1.14 Million	-31,088 Reduced 88.89%	3,885 $556,000
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $73,369 - $105,495	4,183 Added 13.59%	34,973 $3.32 Million
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $4,009 - $5,691	-307 Reduced 0.99%	30,790 $2.28 Million
Q4 2017 Feb 13, 2018	BUY	$11.12 - $15.38 $689 - $953	62 Added 0.2%	31,097 $1.79 Million
Q3 2017 Nov 14, 2017	SELL	$11.36 - $18.98 $7,895 - $13,191	-695 Reduced 2.19%	31,035 $1.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	31,730	31,730 $2.32 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Account

United Capital Financial Advisers, LLC Dexcom Inc Transaction History